Constellation of arterial hypertension and stable angina pectoris, influence of adipokines and inflammation, the place of amlodipine

V.K. Tashchuk

Abstract


The dynamics of C-reactive protein and leptin indices in patients with arterial hypertension and stable angina pectoris were studied in thus article in comparison with the effects of calcium antagonists.

Keywords


arterial hypertension; stable angina pectoris; C-reactive protein, leptin; amlodipine

References


2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardio­logy / G. Montalescot, U. Sechtem, S. Achenbach [et al.] // Eur. Heart J. — 2013. — Vol. 34, № 38. — Р. 2949-3003.

2013 ESH/ESC Guidelines for the management of arterial hypertension / G. Mancia, R. Fagard, K. Narkiewicz [et al.] // Eur. Heart J. — 2013. — Vol. 34. — Р. 2159-2219.

2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease / S.D. Fihn, J.C. Blankenship, K.P. Alexander [et al.] // Circulation. — 2014. — Vol. 130. — Р. 1749-1767.

A polypill strategy to improve adherence: results from the FOCUS project / J.M. Castellano, G. Sanz, J.L. Peñalvo [et al.] // Sanz. Am. Coll. Cardiol. — 2014. — Vol. 64, № 20. — Р. 2071-2082.

Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study / G. Luc, J.P. Empana, P. Morange [et al.] // Int. J. Obes. (Lond). — 2010. — Vol. 34, № 1. — P. 118-126.

Adiponectin-leptin ratio: A promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk / G. Frühbeck, V. Catalán, A. Rodríguez [et al.] // Adipocyte. — 2017. — Vol. 5. — Р. 1-6.

Association of the genetic and traditional risk factors of ischaemic heart disease with STEMI and NSTEMI development / D. Žaliaduonytė-Pekšienė, V. Lesauskaitė, R. Liutkevičienė [et al.] // J. Renin Angiotensin Aldosterone Syst. — 2017. — Vol. 18, № 4. — doi: 10.1177/1470320317739987.

Hypertension is associated with increased mortality in patients with ischaemic heart disease after revascularization with percutaneous coronary intervention — a report from SCAAR / O. Saluveer, B. Redfors, O. Angerås [et al.] // Blood Press. — 2017. — Vol. 26, № 3. — P. 166-173.

Relation of Coronary Artery Calcium and Extra-Coronary Aortic Calcium to Incident Hypertension (from the Multi-Ethnic Study of Atherosclerosis) / A.I. Aladin, M. Al Rifai, S.H. Rasool [et al.] //

Am. J. Cardiol. — 2017. — Vol. 24. № 17. — Р. 31672-31677.

Tamargo J. The Fuster-CNIC-Ferrer Cardiovascular Polypill: a polypill for secondary cardiovascular prevention / J. Tamargo, J.M. Castellano, V. Fuster // Int. J. Cardiol. — 2015. — Vol. 201, № 1. — Р. 15-22.

Yusuf S. Comparison of risk factor reduction and tolerability of a full-dose polypill (with potassium) versus low-dose polypill (polycap) in individuals at high risk of cardiovascular diseases: the Second Indian Polycap Study (TIPS-2) investigators / S. Yusuf, P. Pais, A. Sigamani // Circ. Cardiovasc. Qual. Outcomes. — 2012. — Vol. 5, № 4. — Р. 463-471.




DOI: https://doi.org/10.22141/2224-1485.6.56.2017.120322

Refbacks

  • There are currently no refbacks.


Copyright (c) 2018 HYPERTENSION

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта